We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

On Eve Of Plavix Trial, Apotex Suffers Another Blow

Law360 (January 19, 2007, 12:00 AM EST) -- The U.S. Court of Appeals for the Federal Circuit has once again handed a setback to Apotex Inc. in its Plavix patent spat with Sanofi-Aventis and Bristol-Myers Squibb Co., denying the Canadian drug maker’s petition to reconsider a ruling that barred it from selling a generic version of the blockbuster blood-thinner.

The Federal Circuit on Friday turned down a petition to rehear a ruling it handed down on Dec. 8 that prevents Apotex from selling its low-cost version of the drug in the United States....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.